SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Baldock R, Bard J, Davidson D, Lawson K. 1998. Mouse developmental staging criteria. Edinburgh mouse atlas project. Available at: http://genex.hgu.mrc.ac.uk/Databases/Anatomy/MAstaging.html. Accessed 7th May 1998.
  • Bard JBL, Kaufman MH. 1999. The anatomical basis of mouse development. London: Academic Press. p 6367.
  • Barlow GM, Chen SN, Shi ZY, Lyons GE, Kurnit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ, Vekemans MJ, Mjaatvedt CH, Korenberg JR. 2001. Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med 3: 91101.
  • Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH, 2000. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Mol Genet 9: 195202.
  • Chaoui R, Heling KS, Sarioglu N, Schwabe M, Dankof A, Bollmann R. 2005. Aberrant right subclavian artery as a new cardiac sign in second- and third-trimester fetuses with Down syndrome. Am J Obstet Gynecol 192: 257263.
  • Conway SJ, Kruzynska-Frejtag A, Kneer PL, Machnicki M, Koushik SV. 2003. What cardiovascular defect does my prenatal mouse mutant have, and why? Genesis 35: 121.
  • Davisson MT, Schmidt C, Reeves RH, Irving NG, Akeson EC, Harris BS, Bronson RT. 1993. Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res 384: 177184.
  • Donti A, Soavi N, Sabbatani P, Picchio FM. 1997. Persistent left fifth aortic arch associated with tetralogy of Fallot. Pediatr Cardiol 18: 229231.
  • Ferencz C, Neill CA, Boughman JA, Rubin JD, Brenner JI, Perry LW. 1989. Congenital cardiovascular malformations associated with chromosome abnormalities: An epidemiologic study. J Pediatr 114: 7986.
  • Haak MC, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM. 2002. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology. Ultrasound Obstet Gynecol 20: 1421.
  • Hiruma, T, Nakajima, Y, Nakamura, H. 2002. Development of pharyngeal arch arteries in early mouse embryo. J Anat 201: 1529.
  • Hogers B, DeRuiter MC, Gittenberger-de Groot AC, Poelmann RE. 1997. Unilateral vitelline vein ligation alters intracardiac blood flow patters and morphogenesis in the chick embryo. Circ Res 80: 472481.
  • Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC. 1996. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 93: 1333313338.
  • Hook EB, Mutton DE, Ide R, Alberman E, Bobrow M. 1995. The natural history of Down syndrome conceptuses diagnosed prenatally that are not electively terminated. Am J Hum Genet 57: 875881.
  • Khan S, Nihill MR. 2006. Clinical presentation of persistent 5th aortic arch 3 new cases. Tex Heart Inst J 33: 361364.
  • Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S, Carpenter N, Daumer C, Dignan P, Disteche C. 1994. Down syndrome phenotypes: the consequences of chromosomal imbalance. PNAS 91: 49975001.
  • Lee M, Chiu I, Fang W, Chen S, Wang Y, Chaou W. 1999. Isolated infundibuloarterial inversion and fifth aortic arch in an infant: a newly recognized cardiovascular phenotypes with chromosome 22q11 deletion. Int J Cardiol 71: 8991.
  • Li Z, Yu T, Morishima M, Pao A, LaDuca J, Conroy J, Nowak N, Matsui S, Shiraishi I, Yu YE. 2007. Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet 16: 13591366.
  • Liu DP, Schmidt, C, Billings, T, Davisson, MT. 2003. Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome. Biotechniques 35: 11701178.
  • Moore CS. 2006. Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse mode. Mamm Genome 17: 10051012.
  • Moore CS, Lee JS, Birren B, Stetten G, Baxter L, Reeves RH. 1999. Integration of cytogenetic with recombinational and physical maps of mouse chromosome 16. Genomics 59: 15.
  • Moore CS, Roper RJ. 2007. The power of comparative and developmental studies for mouse models of Down syndrome. Mamm Genome 10: 100512.
  • Morris JK, Wald NJ, Watt HC. 1999. Fetal loss in Down syndrome pregnancies. Prenat Diagn 19: 142145.
  • O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, Sesay A, Modino S, Vanes L, Hernandez D, Linehan JM, Sharpe PT, Brandner S, Bliss TVP, Henderson DJ, Nizetic D, Tybulewicz VLJ, Fisher EMC. 2005. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309: 20332037.
  • Paz-Miguel JE, Pardo-Manuel de Villena F, Sanchez-Velasco P, Leyva-Cobian F. 2001. H2-haplotype-dependent unequal transmission of the 17(16) translocation chromosome from Ts65Dn females. Mamm Genome 12: 8385.
  • Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS, Glimcher LH. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186190.
  • Rasband WS. Image J, U.S. National Institutes of Health, Bethesda, Maryland, USA. Available at: http://rsb.info.hib.gov/ij/, 1998–2008. Accessed 16 September 2008.
  • Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT. 1995. A mouse model for Down syndrome exhibits learning and behaviour deficits. Genetics 11: 177184.
  • Richtsmeier JT, Zumwalt A, Carlson EJ, Epstein CJ, Reeves RH. 2002. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am J Med Genet 107: 317324.
  • Roper RJ, Reeves RH. 2006. Understanding the basis for Down syndrome phenotypes. PLoS Genet 2: 231236.
  • Roper RJ, St John HK, Philip J, Lawler A, Reeves RH. 2006. Perinatal loss of Ts65Dn Down syndrome mice. Genetics 172: 437443.
  • Roper RJ, Van Horn JF, Cain CC, Reeves RH. 2009. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev 126:212219.
  • Shapiro BL. 1997. Whither Down syndrome critical region? Hum Genet 99: 421423.
  • Spencer K. 2001. What is the true fetal loss rate in pregnancies affected by trisomy 21 and how does this influence whether first trimester detection rates are superior to those in the second trimester? Prenat Diagn 21: 788789.
  • Stevenson RE, Hall JG. 2006. Human malformations and related anomalies. Oxford University Press US. p 127.
  • Theiler K. 1989. The house mouse: atlas of embryonic development. New York: Springer-Verlag. p 7881.
  • Villar AJ, Kim J, De Blank P, Gillespie AM, Kozy HM, Ursell PC, Epstein CJ. 2005. Effects of genetic background on cardiovascular anomalies in the Ts16 mouse. Dev Dyn 232: 131139.
  • Wessels MW, Los FJ, Frohn-Mulder IME, Niermeijer MF, Willems PJ, Wladimiroff JW. 2003. Poor outcome in Down syndrome fetuses with cardiac anomalies or growth retardation. Am J Med Genet 116A: 147151.
  • Williams AD, Mjaatvedt CH, Moore CS. 2008. Characterization of the cardiac phenotype in Neonatal Ts65Dn Mice. Dev Dyn 237: 426435.
  • Wu H, Hoon Lee S, Gao J, Lui X, Iruela-Arispe ML. 1999. Inactivation of erythropoietin leads to defects in cardiac morphologenesis. Development 126: 35973605.